The Ketamine Research Foundation

KRF releases our new publication?Guidelines for the Personal Use and The Clinical Administration of Ketamine?

#matthewperry

#MatthewPerry

There is still room in our advanced Ketamine Training next month! KTC Presents its Advanced Sharing for KAP Practitioners at our beloved Menla Retreat Center in the Catskills September 24th - September 29th, 2024 The Advanced Sharing Retreat is open to KPA and others who have attended different KAP trainings and who have at least begun to practice KAP. It will include group experiences—psycholytic mornings and higher dose afternoons—all IM–and presentations and case discussions. Our program is formed with attendees as a process of mutual interests. We will be soliciting your input into the program. We expect sessions potentially to include: Successes and Failures; Case Presentations as Consultations; Practice Issues; Working in Groups; Couples; Adolescents; Our Various Methodologies; KAP and Sex Therapy; Ketamine and Emerging Psychedelics; Diversity, Identity and Culture; Commercialization and Where We Are Heading; Expanded Awareness and Movement in KAP; Trauma and KAP; Update on Science; Ketamine Abuse and Misuse, Meditation, Rituals and the Ketamine Experience-and other topics as we bring them to our attention. We would conduct the program within a contemplative practice set. Please see this as an opportunity to expand our connections and skillful means. Please see this as an opportunity to come together as a community of devoted practitioners. We are committed to sharing and fun. All of our trainings and events have created kindness and affection. We welcome your application and attendance. As this is a Sharing event, aside from Organizers, Providers, and our Support team, we are not paying for Leaders as we do in our Fundamentals program. In the spirit of collaboration, we are asking applicants to pay their tuition fees on a sliding scale by your own estimate in an honor framework of fees of $3000-$4500. regardless of degree. Fees to Menla for room and board are arranged separately with Menla. BIPOC Scholarships and limited reductions in fees will be processed on request and dependent on registration as we are a non-profit organization. Participants will be requested to provide their suggestions for topics and their potential offerings to add to the scheduling. Zoom sessions will precede the event for planning and participation. Our intention is to have a sharing that elevates all of our practices conceptually, methodologically ,spiritually, and practically. And to support the growth and development of the KAP community of practitioners, and psychedelic assisted psychotherapy. Please apply now as there is large interest in the event based on the results of our survey. Tuition: $3,000 – $4,500 sliding scale? Room and board separate at additional cost payable to Menla. Room reservation is made directly through?Menla after acceptance to the program. Link will be provided at that time. https://lnkd.in/gyhR3VwK

TO BE CLEAR, THE FDA OVVERRULED ITSELF!!! Much as when in 1986, the DEA threw out their own Administrative Law Judge’s ruling that MDMA belonged in Schedule 3, thereby violating their own procedures and the rules of evidence and due process, and thus with illegalization, making this whole 28 year long ordeal occur, with all its consequences, so now FDA repeats the same feat. For in complete truth and subject to review of the correspondence and collaboration with MAPS and now its Lykos emanation, the FDA in fact guided the process, participated in the protocol formation, watched rigorously over the Phase 1, 2, and 3 protocols, ruled on their acceptability for continued development, and assessed safety and structure throughout.?It is pure hypocrisy to have FDA represent otherwise.? The rigor of MAPS’ MDMA development program is far in excess of the usual FDA process and there have been no secrets, save for FDA’s own process and considerations. Theoretically, the FDA is a public agency with all the responsibility and visibility that entails. Apparently, not so.?And this is not new stuff, the agency has been found wanting in its decisions, including overriding evidence and safety concerns with certain drug approvals.? But au contraire with MDMA, there have been no concerns for safety, no demonstrations of adverse effects, stringent oversight of performance and investigators, in other words: NO BASIS FOR NOT APPROVING MDMA OR REQUIRING MORE OF WHAT HAS ALREADY BEEN FAR MORE THAN ADEQUATE PROOF FOR MAKING MDMA AVAILABLE FOR THE RICHNESS OF ITS BENEFITS TO A NEEDY HUMANKIND. As with the DEA ruling, the FDA ruling can only be considered?politically motivated. The conjectures on the attitudes and influences behind the politics are flowing. And they implicate many forces-- from Pharma, to academia, to conventional psychiatry, to individuals with self-interests, to anti-drug politicians, to those who detest the personal and non-institutional exploration of consciousness, healing,?and the freedom that engenders. Undoubtedly, this will unfold. For now, it is essential to make our voices and determination heard and felt.?Obtaining prescriptive availability of MDMA is a necessary and vital part of bringing MDMA into the light.?From all of us who know its value, safety, healing, and its tendency to evoke kindness, tolerance, compassion, and sharing, the FDA must reverse its mandate and let us move on. ---Phil Wolfson MD—a personal statement

Phil Wolfson's latest opinion piece, "A Therapist Responds to the MDMA Imbroglio," offers a compelling and insightful perspective on the ongoing debate surrounding MDMA therapy. Don't miss this thought-provoking read published in Lucid News! https://lnkd.in/gmcuU-9H

KTC Presents Advanced Sharing for KAP Practitioners at Menla Retreat Center in the Catskills - With CEs Available Dates:?September 24th - September 29th, 2024 Join us for the Advanced Sharing Retreat, open to KPA and other practitioners who have attended various KAP trainings and begun practicing KAP. This retreat includes group experiences, psycholytic mornings, higher dose afternoons (all IM), presentations, and case discussions. The program is collaboratively designed with attendee input, ensuring it meets mutual interests. Potential sessions include: Successes and Failures Case Presentations as Consultations Practice Issues Working in Groups Couples and Adolescents Various Methodologies KAP and Sex Therapy Ketamine and Emerging Psychedelics Diversity, Identity, and Culture Commercialization and Future Directions Expanded Awareness and Movement in KAP Trauma and KAP Updates on Science Ketamine Abuse and Misuse Meditation, Rituals, and the Ketamine Experience Conducted within a contemplative practice set, this event aims to expand our connections and skills, fostering a community of dedicated practitioners. We welcome your application and participation. Tuition:?$3,000 – $4,500 (sliding scale, based on honor system). Room and board fees are separate and arranged with Menla. BIPOC Scholarships and limited fee reductions are available upon request, subject to registration as we are a non-profit organization. Participants will be asked to suggest topics and potential offerings for the schedule. Planning and participation will include pre-event Zoom sessions. Our goal is to elevate our practices conceptually, methodologically, spiritually, and practically, supporting the growth and development of the KAP practitioner community. Apply now, as there is significant interest based on our survey results. Room and Board:?Room reservations are made directly through Menla after acceptance to the program. A link will be provided upon acceptance. Apply Now https://lnkd.in/gyhR3VwK

About Ketamine—The Full Story —A Public Discourse BY?PHIL WOLFSON MD?,?AVIVA ZOHAR MD?,?MARK BRAUNSTEIN DO?,?BEN MCCAULEY MAY 14, 2024 ? https://lnkd.in/dbhUPHhU ? The Ketamine Research Foundation and its practitioner authors share our article for awakening a broad and critical?understanding of the spectrum of benefits and hazards of ketamine's use.?As practitioners we are exposed to and probe the personal bases for ketamine's extraordinary positive value to allay human suffering and for its dependence. We offer this work to increase knowledge about ketamine and ketamine assisted psychotherapy?and to further compassionate awareness to individual susceptibilities and experiences. Our article is long and intricate in order to provide a full view. ? And in Memory of Ken Jordan, who honored us with his deeply thoughtful editing, this as his last contribution.

Dr. Phil Wolfson Featured in Oprah Daily Articles https://buff.ly/4a8veMu There are a series of articles featuring the work of Dr. Phil Wolfson that recently appeared in the Oprah Daily magazine. The links to the articles are below. The State of Psychedelics (